Himalaya Nutravedics India IPO Logo

Himalaya Nutravedics India IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Listed
Dates Sep 22 to Sep 24 2026
Price Band ₹100 - 106
Current GMP ₹118 (11.32%)
Subscription 2.33 times

IPO Details

IPO Date
22 to 24 Sep, 2026
Listing Date
Tue, Sep 29, 2026
Face Value
₹ 10 per share
Price Band
₹100 to ₹106
Issue Price
₹106 per share
Lot Size
1,200 Shares
Sale Type
Fresh capital only
Issue Type
Bookbuilding IPO
Listing At
BSE SME
Total Issue Size
24,99,600 shares (agg. up to ₹ 26 Cr)
Reserved for Market Maker
1,26,000 shares (agg. up to ₹ 1 Cr) Allwin Securities Ltd.
Fresh Issue (Ex Market Maker)
23,73,600 shares (agg. up to ₹ 25 Cr)
Net Offered to Public
23,73,600 shares (agg. up to ₹ 25 Cr)
Share Holding Pre Issue
63,06,720 shares
Share Holding Post Issue
88,06,320 shares
BSE Script Code
544943
ISIN
INE1OTR01013

IPO Subscription Details

Anchor
1
Market Maker
1
QIB (Ex Anchor)
1.00
NII***
3.58
bNII (> ₹10L)
3.84
sNII (< ₹10L)
3.04
Individual Investors
2.56
Total **
2.33

Day Wise Sub

DaySep 2 2 (Day 1)
QIB (Ex Anchor)0.00
NII*0.14
NII (> ₹10L)0.10
NII (< ₹10L)0.21
Individual Investors0.16
Total0.11
DaySep 2 3 (Day 2)
QIB (Ex Anchor)0.00
NII*0.32
NII (> ₹10L)0.47
NII (< ₹10L)0.54
Individual Investors0.67
Total0.40
DaySep 2 4 (Day 3)
QIB (Ex Anchor)1.00
NII*3.58
NII (> ₹10L)3.84
NII (< ₹10L)3.04
Individual Investors2.56
Total2.33

Day Wise GMP

GMP Date29-09-2026
IPO Price106
GMP0 (0%)
Est. Listing Price106

IPO Important Dates

IPO Open
Tue, Sep 22, 2026
IPO Close
Thu, Sep 24, 2026
Allotment
Fri, Sep 25, 2026
Refund
Mon, Sep 28, 2026
Credit of Shares
Mon, Sep 28, 2026
Listing
Tue, Sep 29, 2026

IPO Lot Size

ApplicationIndividual investors (IND) (Min)
Lots2
Shares2400
Amount₹2,54,400
ApplicationIndividual investors (IND) (Max)
Lots2
Shares2400
Amount₹2,54,400
ApplicationS-HNI (Min)
Lots3
Shares3600
Amount₹3,81,600
ApplicationS-HNI (Max)
Lots7
Shares8400
Amount₹8,90,400
ApplicationB-HNI (Min)
Lots8
Shares9600
Amount₹10,17,600

Financial Information

Period EndedAssets
31 Mar 202624.42
31 Mar 202510.82
31 Mar 20246.09
Period EndedTotal Income
31 Mar 202643.12
31 Mar 202521.00
31 Mar 202414.43
Period EndedProfit After Tax
31 Mar 20267.39
31 Mar 20252.23
31 Mar 20240.43
Period EndedEBITDA
31 Mar 20268.10
31 Mar 20252.99
31 Mar 20240.94
Period EndedNET Worth
31 Mar 202616.38
31 Mar 20256.75
31 Mar 20241.34
Period EndedReserves and Surplus
31 Mar 202610.07
31 Mar 20252.76
31 Mar 20240.53
Period EndedTotal Borrowing
31 Mar 20265.13
31 Mar 20251.76
31 Mar 20243.24

Key Performance Indicator

ROE
63.87%
ROCE
36.41%
Debt/Equity
0.31
RoNW
45.12%
PAT Margin
17.16%
EBITDA Margin
18.82%
NAV
26.70
Price to Book Value
3.97

IPO Reservation

QIB
11,84,400
− Anchor Investor
7,10,400
− QIB (Ex. Anchor)
4,74,000
NII (HNI)
3,56,400
− bNII > ₹10L
2,37,600
− sNII < ₹10L
1,18,800
Retail
8,32,800
Market Maker
1,26,000
Total
24,99,600

Information about company

Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing and distribution of Ayurvedic and nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies. The Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulations, proprietary Ayurvedic formulations and nutraceutical supplements. Its products are available in multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, liquid orals and medicated oils. The products cater to therapeutic and wellness areas such as gut health, cardiac and metabolic wellness, diabetes management, pain management, immunity, women’s wellness and general wellness. Himalaya Nutravedics operates through a hybrid business model comprising its own branded products and third-party contract manufacturing. Under its own-brand business, the Company develops, manufactures and markets Ayurvedic and nutraceutical products, while its third-party manufacturing business provides formulation, manufacturing, packaging and dispatch services based on client specifications. As of March 31, 2026, its own-brand business contributed approximately ₹2,202.54 lakh, representing about 51.14% of total revenue. The Company operates an integrated manufacturing facility in Hyderabad, Telangana, where formulation, production, quality control, packaging and finished-goods release are carried out internally. The facility is compliant with WHO-GMP standards and holds registrations and licences from AYUSH and FSSAI, along with certifications including ISO 9001:2015, ISO 22000:2018, HACCP, HALAL and KOSHER. As of July 31, 2026, the Company had 86 full-time employees across marketing, factory, finance, quality, compliance and administration functions. Competitive Strengths

Objectives of IPO

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: #: Issue Objects 1: Funding Working Capital Requirements 2: Business Development and Digital Marketing Activities 3: General Corporate Purposes : Total

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App